FDA Investigator Laureen F Kononen

Laureen F Kononen has conducted inspections on 151 sites in 3 countries as of 01 Sep 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
151
Last Inspection Date:
01 Sep 2011
Investigator Role:
FDA Investigator
Redica ID:
100003287
Countries of Inspections:
United States of America, India, Russian Federation
FDA Investigators that have inspected at least one site in common with Laureen F Kononen:
Alanna L Mussawwir Bias, Alexandra A Carrico, Allen F Hall, Amy S Graf, Andrace L Deyampert, Andrea D Swingle, Andrea F White, Angela J Alexander, Anita Narula, PhD, Ann Raju Daniel, Anthony F Lorenzo, Anthony R Petriella, Art O Czabaniuk, Ashley E Lewis, Aurora Miha Trifanov, Azza Talaat, Barbara A Rusin, Bei Y He, Brandon L Mariner, Brian J Mundo, Brian P Putz, Byron Ho, DVM, Carla V Jordan, Carmen M Faraianu, Caroline H Le, Carolyn J Oyster, Catherine V Quinlan, Cathie S Marshall, CDR Kimberly Y Martin, Charles A Snipes, PhD, Christi L Bellmore, Christian D Lynch (CDL), Corrine M Carter, Crystal M Young Lewis, Cynthia L Aycock, Cynthia Li, Daniel J Brown, Danny Tuntevski, David J Gasparovich, David L Wilson, David P Moorhead, Dawn C Olenjack, Deanna L Lampley, Deborah M Trout, Denise L Burosh, Dina A Tallman, Dr. Gopa Biswas, PhD, Emilie E Kahn, Emily B Camire, Emily J Orban, Eric E Joneson, Erica N Koory, Erma Zaimova, Felicia E Armbrustmacher, Gary Durbiel Goldner, Gary R Dzidowski, Hassan M Fakhreddine, Hokenson, Ifueko Osemwota, Ita Yuen, PhD, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James E Szelc, James R Evans, James W Leonette, Jeffrey D Meng, Jeffrey O Hilgendorf, Jennifer A Kemp, Jennifer L Sheehan, Joanne E King, John N Woodall, Joohi Castelvetere, Joseph A Piechocki, Joseph T Madak, Judith A Jankowski, Justin M Tomczak, Kathryn A Cutajar, Kathryn A Guardiola, Kathryn E Ogger, Keith A Schwartz, Kelley L Clark, Kellie L Thommes, RN, Kelly A Sparks, Kristina Mezin, Kristina Nastovski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Lauren E Burke, Lauren E Sexton, Lauren M Lilly, PhD, LCDR Anastasia M Piliafas Brown, Lee Terry Moore, Leena Thomas, Leroy Terrelonge, Lesley Maep Lutao, Leslie A Paul, Lewis K Antwi, Linda S Jozefiak, Lindsey Brown, PhD, Lisa J Joseph, Lisa J Renick, Lisa M Thursam, Lisa P Oakes, LT Danielle S Mills, LT Skip A Payne, Maira P Brading, Marcus L Head, Margaret N Persich, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Miah I Schneider, Michael Shanks, MS, Michele L Forster, PhD, Michelle D Haamid, Michelle L Jones, Mihaly S Ligmond, Minerva Rivera, Myra K Casey, Nancy A Bellamy, Nancy L Meade, Neali H Lucas, Nicholas J Presto, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Paige E Wilson, Patsy J Domingo, Paula J Bretz, Perry H Gambrell, Phenicia T Petty, Prabhu P Raju, Preston M Lee, Rasha Bamieh, Rebecca A Olotu, Rebecca E Dombrowski, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Robert G Taylor, Robert M Barbosa, Robert P Whisenant, Roger A Hartman, Rohn R Robertson, Rose Ashley, Ryan J Benedict, Sally S Eberhard, Salwa K Poole, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Scott B Laufenberg, Sherri J Blessman, Sherri J Jackson, Sherri L Clark, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Sripal R Mada, PhD, Susan M Jackson, Susan M North, Suyang Qin, Theodore N Sietsema, Thomas A Peter, Timothy A Riles, Tina M Pawlowski, Tina S Roecklein, Tracey L Siebesma, Tracey L Taylor, Travis S Bradley, Twana R Chandler, Tyra L Vanleer, Vanessa J Colburn, Vesa Vuniqi, Victoria A Murray, William D Bassett, Jr, William D Tingley

Laureen F Kononen's Documents

Publish Date Document Type Title
June, 2003 FDA 483 Pfizer, Inc. - Form 483, 2003-06-12
September, 2001 FDA 483 Kath Khemicals LLC - Form 483, 2001-09-28
October, 2005 EIR Pfizer, Inc. - EIR, 2005-10-05
April, 2001 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2001-05-25
July, 2008 FDA 483 Reproductive Care Of Indiana, PC - Form 483, 2008-07-31
September, 2005 FDA 483 Response Pfizer, Inc. - Form 483R, 2005-09-15
June, 2003 FDA 483 Response Pfizer, Inc. - Form 483R, 2004-05-06
June, 2001 EIR Pfizer, Inc. - EIR, 2001-06-21
September, 2005 FDA 483 Pfizer, Inc. - Form 483, 2005-09-15
April, 2001 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2001-04-25
July, 2008 FDA 483 Center For Reproductive Biology Of Indiana, LLC - Form 483, 2008-09-22
September, 2001 FDA 483 Response Abbott Laboratories - Form 483R, 2001-09-28
June, 2002 FDA 483 Xela Pack, Inc. - Form 483, 2002-06-07
April, 2001 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2001-04-25
June, 2003 EIR Pfizer, Inc. - EIR, 2003-06-12
September, 2005 EIR Pfizer, Inc. - EIR, 2005-09-15
October, 2005 FDA 483 Pfizer, Inc. - Form 483, 2005-10-05
March, 2003 FDA 483 Biological Research Solutions, Inc. - Form 483, 2003-03-12
May, 2011 FDA 483 DLP Marquette General Hospital, LLC - Marquette - Form 483, 2011-05-26
December, 2001 FDA 483 ENDO USA, Inc. - Form 483, 2001-12-07
June, 2007 FDA 483 Pfizer, Inc. - Form 483, 2007-06-18
September, 2001 EIR Abbott Laboratories - EIR, 2001-09-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more